Journal
NEUROCHEMICAL RESEARCH
Volume 37, Issue 6, Pages 1230-1244Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11064-012-0744-y
Keywords
Glycosyltransferase; Ganglioside synthase; Gangliosides; Knockout mouse; Lipid raft; Neurodevelopment; Neurological disease
Categories
Funding
- USPHS [NS11853-36, NS26994-21]
- Veteran's Administration [1IO1BX001388-01]
- Children's Medical Research Foundation, Chicago, IL
Ask authors/readers for more resources
Gangliosides are sialic acid-containing glycosphingolipids that are most abundant in the nervous system. They are localized primarily in the outer leaflets of plasma membranes and participated in cell-cell recognition, adhesion, and signal transduction and are integral components of cell surface microdomains or lipid rafts along with proteins, sphingomyelin and cholesterol. Ganglioside-rich lipid rafts play an important role in signaling events affecting neural development and the pathogenesis of certain diseases. Disruption of gangloside synthase genes in mice induces developmental defects and neural degeneration. Targeting ganglioside metabolism may represent a novel therapeutic strategy for intervention in certain diseases. In this review, we focus on recent advances on metabolic and functional studies of gangliosides in normal brain development and in certain neurological disorders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available